Puma Biotechnology (PBYI) Earns Overweight Rating from Analysts at Cantor Fitzgerald

Cantor Fitzgerald began coverage on shares of Puma Biotechnology (NASDAQ:PBYI) in a report issued on Monday, October 1st, Marketbeat reports.

Leave a Comment